Using a special MRI to predict rectal cancer response to pre-surgery therapy
Part of Cancer, Digestive system clinical trials.
This trial uses a special type of MRI scan (called amide proton transfer-weighted imaging) to look at your rectal cancer before and after chemotherapy and/or radiation. The goal is to see if the scan can predict whether the cancer has completely disappeared by the time of surgery, which could help guide future treatment decisions.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have advanced rectal cancer that has grown into or beyond the rectal wall or spread to nearby lymph nodes, but it can still be surgically removed.
- You have already had chemo and/or radiation therapy for your rectal cancer before surgery.
- You had a complete surgery to remove the rectal cancer, and the removed tissue will be checked under a microscope.
- You are willing and able to sign a consent form after understanding what the study involves.
- You do not have severe bowel blockage or a hole in the bowel that requires emergency surgery.
- You have no history of other cancers, and you are not unable to have an MRI (e.g., due to metal implants or severe anxiety).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses an AI computer program to read special MRI images and predict how well treatment (given before surgery) will work for people with locally advanced rectal cancer. It may help doctors better plan who benefits most from neoadjuvant therapy (treatment before surgery).
This study uses special MRI scans taken before and during immunotherapy to see if the cancer is truly growing or just appearing to grow, which is called 'pseudoprogression'. It helps doctors better understand how well the treatment is working for rectal cancer.
This study uses MRI scans to try to predict whether your rectal cancer completely disappears after pre-surgery chemoradiotherapy. The goal is to better personalize treatment decisions, possibly helping some patients avoid surgery.
This study looks at how an MRI “score” (mrTRG) matches how well locally advanced rectal cancer shrinks after pre-surgery chemotherapy and radiation. The goal is to use MRI results to better predict treatment response and guide care.
This study looks at whether a special scan called PET-MRI can better show how rectal cancer responds to treatment given before surgery. If it works well, it could help doctors plan the right next steps after chemoradiotherapy.
This trial uses a special MRI before treatment to better understand early rectal cancer or suspicious large polyps. It may help doctors choose care that avoids bigger surgery when possible.
Hear when a new Rectal Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.